Fresenius Medical Care AG ADR(FMS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 10 at 4:00 PM ET (Korea 9/11 05:00)
Full metrics table
| Index | - | P/E | 11.47 | EPS (ttm) | 1.94 | Insider Own | - | Shs Outstand | 532.2M | Perf Week | -1.85% |
| Market Cap | 11.83B | Forward P/E | 9.05 | EPS next Y | 4.21% | Insider Trans | - | Shs Float | 532.2M | Perf Month | -6.87% |
| Enterprise Value | 24.27B | PEG | 2.39 | EPS next Q | 0.61 | Inst Own | 7.99% | Short Float | 0.52% | Perf Quarter | -0.22% |
| Income | 1.09B | P/S | 0.52 | EPS this Y | -6.46% | Inst Trans | 0.51% | Short Ratio | 4.14 | Perf Half Y | -2.29% |
| Sales | 22.66B | P/B | 0.82 | EPS next 5Y | 3.78% | ROA | 3.02% | Short Interest | 2.77M | Perf YTD | -6.68% |
| Book/sh | 26.97 | P/C | 9.75 | EPS past 3/5Y | 16.25% -3.43% | ROE | 7.3% | 52W High | -19.57% ($27.64) | Perf Year | -10.58% |
| Cash/sh | 2.28 | P/FCF | 5.65 | Sales past 3/5Y | 2.83% 1.71% | ROIC | 4.51% | 52W Low | 11.04% ($20.02) | Perf 3Y | 4.32% |
| Dividend Est. | $0.83 (3.72%) | EV/EBITDA | 5.85 | EPS Y/Y TTM | 57.96% | Gross Margin | 26.36% | Volatility(W/M) | 1.38% 1.35% | Perf 5Y | -39.06% |
| Dividend TTM | 0.86 | EV/Sales | 1.07 | Sales Y/Y TTM | 6.76% | Oper. Margin | 10.9% | ATR (14) | 0.38 | Perf 10Y | -49.53% |
| Dividend Ex-Date | 2026/5/22 | Quick Ratio | 0.75 | EPS Q/Q | 8.69% | Profit Margin | 4.82% | RSI (14) | 29.53 | Recom | 4 |
| Dividend Gr. 3/5Y | 13.25% 1.37% | Current Ratio | 1.07 | Sales Q/Q | 4.06% | SMA20 | -3.82% ($23.11) | Beta | 0.72 | Target Price | $20.8 |
| Payout | 31.98% | Debt/Eq | 0.87 | Earnings | 2026/8/3 | SMA50 | -6.64% ($23.81) | Rel Volume | 0.69 | Prev Close | $22.33 |
| Employees | 111024 | LT Debt/Eq | 0.69 | EPS/Sales Surpr. | 5.07% 2.22% | SMA200 | -3.8% ($23.11) | Avg Volume(3M) | 0.67M | Price | $22.23 |
| IPO | 1996/9/17 | Option/Short | Yes/Yes | Trades | 4071 | Volume | 459,882 | Change | -0.45% |
Company
FMS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A German healthcare company and a global dialysis specialist that provides kidney dialysis treatment services along with dialysis equipment and supplies. It is listed on the US stock exchange as an ADR, with its performance driven by the number of dialysis patients and healthcare cost policies.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
FMS earns at a steady pace
10.9% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -6.5% this year.
Tap to view numbers
The stock looks undervalued
Trading at 11.5 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Sell.
Tap to view numbers
Holding long would have lost money
Would have changed by +4.3% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 3.72% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 8.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PZLV 0.02%
BAIV 0.02%
BINV 0.02%
PZIV 0.02%
SAGP 0.02%It ranks #4 in the industry
Based on market cap of $12B.
FMS $12B PER 11.5
HCA $91B PER 14.1
THC $21B PER 10.2
EHC $12B PER 19.7
FAQ
What kind of company is FMS?
FMS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of FMS?
The market cap of FMS is approximately $11.8B, ranking 844 within its sector.
Does FMS pay dividends?
FMS has a dividend yield of approximately 3.72%, with an annual dividend of $0.83.
What is the P/E ratio of FMS?
FMS has a P/E ratio of approximately 11.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for FMS?
FMS has recorded a 52-week high of $27.64 and a low of $20.02.
